More about Congenital Athymia
Congenital athymia can arise from several causes. The most common is 22q11.2 deletion syndrome (DiGeorge syndrome), where deletion of a chromosomal segment disrupts pharyngeal pouch development including thymus formation. Other causes include CHARGE syndrome, mutations in FOXN1 (the nude phenotype), and maternal diabetes during pregnancy.
Keep reading about Congenital Athymia
Historically, congenital athymia was uniformly fatal within the first few years of life without bone marrow transplant, which has limited efficacy because the transplanted stem cells still lack a thymic environment for T-cell maturation.
Enzyvant's RETHYMIC (allogeneic processed thymus tissue), FDA-approved in October 2021, provides donor thymus tissue that is surgically implanted, allowing the patient's own T-cell precursors to undergo thymic education. This regenerative approach restores immune function in the majority of treated patients.
What are the symptoms of Congenital Athymia?
These are common symptoms of Congenital Athymia, and how strong they are varies from person to person.
- Recurrent or persistent severe infections beginning in the first months of life
- Chronic or recurrent pneumonia
- Chronic diarrhea and gastrointestinal infections
- Persistent oral thrush or skin yeast infections
- Failure to thrive and difficulty gaining weight
- Susceptibility to opportunistic infections like CMV and fungal infections
Who gets Congenital Athymia?
Present from birth. Detected through newborn SCID screening (T-cell receptor excision circles, or TRECs). Affects males and females equally. Can occur as part of 22q11.2 deletion syndrome (DiGeorge syndrome), CHARGE syndrome, FOXN1 deficiency, or diabetic embryopathy. Most patients are identified in the first year of life.
Next steps: find trials you might fitsee approved treatmentsget help payingget alerts
Which medicines are FDA-approved for Congenital Athymia?
There is currently 1 FDA-approved medication for Congenital Athymia.
Source: openFDA drug labeling data. This list may not include all treatments. Always consult your doctor.
How to get help paying for Congenital Athymia treatment
Charity funds and drugmaker programs for Congenital Athymia, checked at the source.
Side effects people have reported to the FDA
Side effects people have reported to the FDA
Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.
Loading side effect data...
Diagnosis and genetic testing
Genetic testing for Congenital Athymia
Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.
Finding labs...
Trusted Congenital Athymia resources
Reputable organizations and medical references for learning more about Congenital Athymia, including disease registries, foundation resources, and clinical guidelines.